Clinical Trial

PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.

Study acronym: PET-ART
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2024 (before its estimated June 22, 2025 completion). Its status may not reflect the trial's current state.
Summary
There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-01-30; most recent amendment 2024-09-25.
Status change: Not Yet Recruiting → Recruiting 2024-02-27
Trial Details
NCT Number NCT06247163
Lead Sponsor University Hospital, Essen
Conditions Small Cell Lung Carcinoma
Enrollment 30 participants
Start Date 2024-02-22
Primary Completion 2025-06-22 (estimated)
Study Completion 2029-06-22 (estimated)
Updated on ClinicalTrials.gov 2024-09-27